COMMUNIQUÉS West-GlobeNewswire

GloraMD Face Lift Serum Claims Evaluated: Liquid Anti-Aging Wrinkle Serum Solution for Skin Renewal
14/04/2026
A GloraMD Product Overview: Peptide Ingredients, Wrinkle Reduction Positioning, Anti-Aging Serum Formula Details, and Consumer Information for 2026 Los Angeles, April 13, 2026 (GLOBE NEWSWIRE) -- Affiliate Disclosure: [...]
Elite Force XL Male Enhancement Gummies Claims Evaluated: Effective Men's Formula for Steel Power Support
14/04/2026
A 2026 informational overview of Elite Force XL's male performance gummy formula, testosterone support positioning, ingredient category context, and what men seeking steel power should verify before purchasing New York [...]
Vital Step GLP-1 Claims Evaluated: Trusted Doctor-Prescribed GLP-1 Weight Loss Medication with No Hidden Fees
14/04/2026
A 2026 program overview covering how Vital Step structures its doctor-prescribed compounded semaglutide and tirzepatide programs, monthly pricing, prescription access, and what adults considering medically supervised [...]
Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support
14/04/2026
A 2026 Informational Overview of CleanEye Vision Care Capsules, Retina Support Ingredient Categories, Lutein and Zeaxanthin Research Context, and Label Transparency for Eye Wellness Supplements Largo, FL, April 13, 2026 [...]
Celldex to Present at Upcoming Investor Conference
13/04/2026
HAMPTON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at H.C. Wainwright’s 4th Annual Inflammatory Skin Disease Virtual Conference on [...]
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
14/04/2026
IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial [...]
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
13/04/2026
EMERYVILLE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases [...]
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
13/04/2026
NEW YORK, 13 avr. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
13/04/2026
WALTHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose [...]
Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
13/04/2026
SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and [...]
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
13/04/2026
NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Cellectis (or the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13/04/2026
SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
AIM ImmunoTech Provides Routine Update on Annual Filings
14/04/2026
OCALA, Fla., April 13, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today advised that its audited consolidated financial statements for the fiscal year ended December 31, [...]
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
13/04/2026
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will include processes [...]
Celebrating National Medical Laboratory Week
13/04/2026
Proud to recognize dedicated and caring medical laboratory professionals who empower healthier Canadians Toronto, Ontario, April 13, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic [...]
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
13/04/2026
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its intention [...]
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
13/04/2026
PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and [...]
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
13/04/2026
• VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" [...]
IBA – ACQUISITION D’ACTIONS PROPRES
13/04/2026
Louvain-la-Neuve, Belgique, 13 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]

Pages